VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 168 filers reported holding VIKING THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,307,000 | +4.8% | 208,102 | 0.0% | 0.48% | +7.2% |
Q2 2021 | $1,247,000 | -5.2% | 208,102 | 0.0% | 0.44% | -21.3% |
Q1 2021 | $1,316,000 | +7.2% | 208,102 | -4.6% | 0.56% | +1.3% |
Q4 2020 | $1,228,000 | -3.2% | 218,102 | 0.0% | 0.56% | -25.4% |
Q3 2020 | $1,269,000 | -19.3% | 218,102 | 0.0% | 0.74% | -13.3% |
Q2 2020 | $1,573,000 | +54.1% | 218,102 | 0.0% | 0.86% | +33.4% |
Q1 2020 | $1,021,000 | -41.6% | 218,102 | 0.0% | 0.64% | -9.2% |
Q4 2019 | $1,749,000 | +16.5% | 218,102 | 0.0% | 0.71% | +12.4% |
Q3 2019 | $1,501,000 | -17.1% | 218,102 | 0.0% | 0.63% | -17.4% |
Q2 2019 | $1,810,000 | -16.5% | 218,102 | 0.0% | 0.76% | -11.6% |
Q1 2019 | $2,168,000 | +19.1% | 218,102 | -8.4% | 0.86% | +0.9% |
Q4 2018 | $1,821,000 | -55.8% | 238,102 | +0.6% | 0.86% | -36.0% |
Q3 2018 | $4,122,000 | +76.2% | 236,600 | -4.1% | 1.34% | +52.5% |
Q2 2018 | $2,340,000 | +121.2% | 246,600 | +1.9% | 0.88% | +101.1% |
Q1 2018 | $1,058,000 | +12.3% | 242,000 | +4.3% | 0.44% | +16.3% |
Q4 2017 | $942,000 | – | 232,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 250,000 | $2,005,000 | 5.90% |
Sio Capital Management, LLC | 731,453 | $5,866,000 | 1.40% |
KNOTT DAVID M | 218,102 | $1,749,000 | 0.71% |
ArrowMark Colorado Holdings LLC | 8,813,578 | $70,685,000 | 0.63% |
DAFNA Capital Management LLC | 209,200 | $1,678,000 | 0.58% |
Park West Asset Management LLC | 1,545,075 | $12,391,000 | 0.52% |
SPHERA FUNDS MANAGEMENT LTD. | 590,000 | $4,732,000 | 0.39% |
Cornerstone Capital, Inc. | 245,796 | $1,971,000 | 0.28% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |